Dr. Gilson Khang was born in 1960 in South Korea, where he obtained his degrees at the Inha Univ (B.S. and M.S.). In 1987, he joined the Dr Hai Bang Lee’s Biomaterials Lab at KRICT (Deajeon, Korea). He was studying for Ph.D. degree at the Department of Biomedical Engineering, The Univ of Iowa (Iowa City, IA, USA) from 1991~1995 under the guidance of Prof Joon B. Park. His academic career started at the Department of PolymerNano Science and Technology at Chonbuk National University (CBNU) and then tenured by Full Professor in 2009.
From 2006 to 2011, he was the PI of BK-21 (Brain Korea 21 Project) and WCU (World Class University, 3MUD/yr for 5 years) Program at CBNU supported by KMEST. He was Chair Professor in the Department of BIN Fusion Technology of WCU program of CBNU.
Dr. Khang was the one of Founder Members of Asian Tissue Engineering Society (ATES) and one of Founder Members of TERMIS-AP Chapter. Prof. Khang was General Secretary and Treasurer for 2005~2009 of TERMIS-AP Chapter and now served as a council member for TERMIS-AP. Recently, he is TERMIS-AP Past-President, & TERMIS Global President-Elect (2016~2018).
He has co-authored or edited ~30 books. He has published ~600 original research papers, and ~200 editorials, reviews or chapters in books. His papers were cited 15,520 times. (h-index >68) His major scientific contribution has been to appreciate and analyze the importance of natural/synthetic hybrid scaffold to reduce the host inflammation reaction as well as the commercialization for tissue engineered products as cartilage, bone, retinal pigment epithelium, cornea endothelium, etc.
His international collaboration network is really worldwide and tight over 7 countries and 15 Universities. He is engaging the Visiting Professor of Tsinghua Univ, Peking Univ, Zhejiang Univ, China and Wake Forest Institute of Regenerative Medicine, USA.